Table 3 |
|||
|
Performance for human using EST evidence. Sensitivity (Sn) and specificity (Sp) were evaluated at the gene, exon and nucleotide levels and reported as percentages. Also shown are the average number of genes and exons predicted for each cross-validation fold. The column headings indicate the predictor and informants used. |
|||
| N-SCAN_EST (mouse + ESTs) |
CONTRAST (mouse + ESTs) |
CONTRAST (11 informants + ESTs) |
|
|
|
|||
| Gene Sn |
46.8 |
60.7 |
65.4 |
| Gene Sp |
31.7 |
40.6 |
46.2 |
| Exon Sn |
89.7 |
92.6 |
93.9 |
| Exon Sp |
66.9 |
74.8 |
76.2 |
| Nucleotide Sn |
93.7 |
95.7 |
96.7 |
| Nucleotide Sp |
69.3 |
74.3 |
75.8 |
| Genes predicted |
23,339 |
23,787 |
22,507 |
| Exons predicted |
202,111 |
203,253 |
202,342 |
|
|
|||
|
Gross et al. Genome Biology 2007 8:R269 doi:10.1186/gb-2007-8-12-r269 |
|||
